Greg Stokes

Biography

Greg Stokes is President and Chief Operating Officer of NovaSom, and has 25 years of pharmaceutical and medical device experience, having worked in sales, marketing, and business development. Prior to NovaSom, he co-founded and served as Executive Vice President of Business Development at Oceana Therapeutics (acquired by Salix for $300 million). Previous positions include co-founder, President and Chief Operating Officer of Esprit Pharma, Inc. (acquired by Allergan for $360 million), Vice President of Corporate Development for ESP Pharma (acquired by Protein Design Labs for $500 million), and Director of Business Development with Shire. Greg received a BA from University of Pennsylvania, JD from Rutgers University and MBA from Rutgers University.

Research Interest

 Cancer